Horizon Therapeutics Public Ltd Co

ADAGE CAPITAL PARTNERS GP, L.L.C.

Report date

9/30/2023

Quarter

2023 Q3

Filed

11/14/2023

Shares

2,936,633

Value ($000)

339,739

Weight

0.8%

2019 Q4 - 2023 Q3 (15 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	11/14/2023	339,739	0.8%	2,936,633	9/30/2023
2023 Q2	8/14/2023	307,995	0.7%	2,994,606	6/30/2023
2023 Q1	5/15/2023	279,280	0.6%	2,558,912	3/31/2023
2022 Q4	2/14/2023	175,673	0.4%	1,543,700	12/31/2022
2022 Q3	11/14/2022	62,276	0.2%	1,006,243	9/30/2022
2022 Q2	8/15/2022	9,372	0.0%	117,500	6/30/2022
2022 Q1	5/16/2022	39,980	0.1%	380,000	3/31/2022
2021 Q4	2/14/2022	16,164	0.0%	150,000	12/31/2021
2021 Q3	11/15/2021	208,674	0.4%	1,905,000	9/30/2021
2021 Q2	8/16/2021	210,690	0.4%	2,250,000	6/30/2021
2021 Q1	5/17/2021	147,264	0.3%	1,600,000	3/31/2021
2020 Q4	2/16/2021	179,218	0.4%	2,450,000	12/31/2020
2020 Q3	11/16/2020	286,699	0.7%	3,690,772	9/30/2020
2020 Q2	8/14/2020	180,966	0.5%	3,255,949	6/30/2020
2019 Q4	2/14/2020	36,200	0.1%	1,000,000	12/31/2019